Apostrophe, a new startup that makes it easier to get Rx acne medications and treatments, has today announced the close of a $6 million seed round led by SignalFire, with participation from FJ Labs.

Apostrophe connects users with board-certified dermatologists, who then develop a personalized Rx treatment plan for those patients. Apostrophe has a vertically integrated mail-order pharmacy, which facilitates the distribution of those treatment plans.